Elicio Therapeutics, Inc. Effective Tax Rate
Elicio Therapeutics, Inc. (ELTX) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-12
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2022-09-30 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2022-06-30 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2022-03-31 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Elicio Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-29 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-14 | 0.00% 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-15 | 0.00% 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-17 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-14 | 0.00% 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-15 | 0.00% 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-30 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-12 | 0.00% 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-12 | 0.00% 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |